These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 28438515)

  • 41. Predictors of Hemorrhage Volume after Intravenous Thrombolysis.
    Shon SH; Heo SH; Kim BJ; Choi HY; Kwon Y; Yi SH; Lee JS; Kim YS; Kim HY; Koh SH; Chang DI
    J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2543-8. PubMed ID: 27444521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Absolute blood eosinophil count could be a potential biomarker for predicting haemorrhagic transformation after intravenous thrombolysis for acute ischaemic stroke.
    Jucevičiūtė N; Mikužis P; Balnytė R
    BMC Neurol; 2019 Jun; 19(1):127. PubMed ID: 31195995
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preexisting dual antiplatelet treatment increases the risk of post-thrombolysis intracranial hemorrhage in Chinese stroke patients.
    Pan Y; Chen Q; Liao X; Zhao X; Wang C; Liu G; Liu L; Wang C; Wang D; Wang Y; Wang Y;
    Neurol Res; 2015 Jan; 37(1):64-8. PubMed ID: 24861494
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models.
    Li M; Wang-Qin RQ; Wang YL; Liu LB; Pan YS; Liao XL; Wang YJ; Xu AD
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1235-43. PubMed ID: 25891755
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fibrinogen decrease after intravenous thrombolysis in ischemic stroke patients is a risk factor for intracerebral hemorrhage.
    Vandelli L; Marietta M; Gambini M; Cavazzuti M; Trenti T; Cenci MA; Casoni F; Bigliardi G; Pentore R; Nichelli P; Zini A
    J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):394-400. PubMed ID: 25497721
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative Analysis on Low- and Standard-Dose Regimes of Alteplase Thrombolytic Therapy for Acute Ischemic Stroke: Efficacy and Safety.
    Zhao G; Huang T; Zheng M; Cui Y; Liu Y; Cheng Z; Wang Z
    Eur Neurol; 2018; 79(1-2):68-73. PubMed ID: 29241193
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prediction of Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke: The Symptomatic Intracranial Hemorrhage Score.
    Lokeskrawee T; Muengtaweepongsa S; Patumanond J; Tiamkao S; Thamangraksat T; Phankhian P; Pleumpanupat P; Sribussara P; Kitjavijit T; Supap A; Rattanaphibool W; Prisiri J
    J Stroke Cerebrovasc Dis; 2017 Nov; 26(11):2622-2629. PubMed ID: 28826584
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and Efficacy of Reperfusion Therapies for Acute Ischemic Stroke Patients with Active Malignancy.
    Sallustio F; Mascolo AP; Marrama F; Koch G; Alemseged F; Davoli A; Da Ros V; Morosetti D; Konda D; Diomedi M
    J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2287-2291. PubMed ID: 31208820
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neutrophil-to-Lymphocyte Ratio and Response to Intravenous Thrombolysis in Patients with Acute Ischemic Stroke.
    Pektezel MY; Yilmaz E; Arsava EM; Topcuoglu MA
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1853-1859. PubMed ID: 31072698
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.
    Al-Khaled M; Matthis C; Eggers J
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low Alberta stroke program early computed tomography score within 3 hours of onset predicts subsequent symptomatic intracranial hemorrhage in patients treated with 0.6 mg/kg Alteplase.
    Hirano T; Sasaki M; Tomura N; Ito Y; Kobayashi S;
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):898-902. PubMed ID: 21737309
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
    Anaissie JE; Monlezun DJ; Siegler JE; Waring ED; Dowell LN; Samai AA; George AJ; Kimbrough T; Berthaud J; Martin-Schild S
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2603-2609. PubMed ID: 27476340
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Four-Year Experience of Symptomatic Intracranial Hemorrhage Following Intravenous Tissue Plasminogen Activator at a Comprehensive Stroke Center.
    Orlando A; Wagner JC; Fanale CV; Whaley M; McCarthy KL; Bar-Or D
    J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):969-76. PubMed ID: 26856464
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Fall in Systolic Blood Pressure 24 Hours after Thrombolysis for Acute Ischemic Stroke Is Associated with Early Neurological Recovery.
    Gill D; Cox T; Aravind A; Wilding P; Korompoki E; Veltkamp R; Kar A
    J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1539-43. PubMed ID: 27053029
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute Ischemic Stroke Therapy in Infective Endocarditis: Case Series and Systematic Review.
    Marquardt RJ; Cho SM; Thatikunta P; Deshpande A; Wisco D; Uchino K
    J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2207-2212. PubMed ID: 31129109
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intravenous thrombolysis with tissue-plasminogen activator in small vessel occlusion.
    Paek YM; Lee JS; Park HK; Cho YJ; Bae HJ; Kim BJ; Park JM; Lee SJ; Cha JK; Park TH; Lee KB; Lee J; Lee BC; Kim JT; Kim DE; Shin DI; Kim WJ; Sohn SI; Choi JC; Hong KS
    J Clin Neurosci; 2019 Jun; 64():134-140. PubMed ID: 30952555
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors of symptomatic intracranial haemorrhage in patients with an ischaemic stroke with neurological deterioration after intravenous thrombolysis.
    James B; Chang AD; McTaggart RA; Hemendinger M; Mac Grory B; Cutting SM; Burton TM; Reznik ME; Thompson B; Wendell L; Mahta A; Siket M; Madsen TE; Sheth KN; Nouh A; Furie KL; Jayaraman MV; Khatri P; Yaghi S
    J Neurol Neurosurg Psychiatry; 2018 Aug; 89(8):866-869. PubMed ID: 29487169
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peripheral Monocyte Count Predicts Outcomes in Patients with Acute Ischemic Stroke Treated with rtPA Thrombolysis.
    Dong X; Nao J; Gao Y
    Neurotox Res; 2020 Feb; 37(2):469-477. PubMed ID: 31478125
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lipid profile, lipid-lowering medications, and intracerebral hemorrhage after tPA in get with the guidelines-stroke.
    Messé SR; Pervez MA; Smith EE; Siddique KA; Hellkamp AS; Saver JL; Bhatt DL; Fonarow GC; Peterson ED; Schwamm LH
    Stroke; 2013 May; 44(5):1354-9. PubMed ID: 23493734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.